The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Voting is now open for the 2024 Company of the Year Awards
137 search results
An industry consortium is tackling one of pharma’s biggest drug-related challenges.
Yvonne Duckworth lays out insights into Pharma 4.0 gleaned in a recent report by CRB. VR, AR, AI: is it more than just alphabet soup?
With so many new dosage forms being seen in pharma, a problem is emerging: the need for novel excipients. Watch our video to learn more.
How did pharma fare during 2021 and will the industry move forward as the pandemic continues to impact lives on a global scale?
Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.
How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.
It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.
A whistle-stop tour of the mechanisms, benefits, manufacturing challenges, and clinical potential of CAR T cells, TCR T cells, TILs, and NK cells.
Anshul Mangal and Tony Khoury of Project Farma weigh in on ways to address the cell and gene therapy skills gap in the US.
On-dose authentication technology can help deter counterfeiters, while also helping patients better engage with their medicines.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
What’s Happening with CAR T Therapies?
Pharma’s Portal to the Lab of the Future
The Sulforaphane Promise